Sinead Delany-moretlweMSc, MD, MBBCh, PhD, DTM&H
Dr Sinéad Delany-Moretlwe is Director of Research at Wits RHI. She trained as a medical doctor at the University of the Witwatersrand in South Africa, and obtained both an MSc in International Health and Tropical Medicine and a PhD in Clinical Epidemiology from the London School of Hygiene and Tropical Medicine (LSHTM).
Dr Delany-Moretlwe has an active interest in the prevention and control of sexually transmitted infections (STIs), including HIV. She has been an investigator on several international multi-centre trials evaluating new technologies for HIV prevention, including genital herpes treatment and novel microbicides. She is currently an investigator on the FACTS 001 multi-centred South African trial of tenofovir 1% gel; and is also involved in research on the prevention of human papilloma virus (HPV) in high HIV-prevalence settings.
Dr Delany-Moretlwe is an active post-graduate lecturer, supervisor and examiner in sexual and reproductive health and epidemiology. She has served on national advisory committees and as a technical adviser for WHO. Dr Delany-Moretlwe has received several awards including the Best Emerging Woman Scientist from the South African Department of Science and Technology (2006), and a South African National Research Foundation Thuthuka Award (2006).